Previous 10 | Next 10 |
Despite possessing solid long-term growth prospects on the back of rising demand from an aging population, many healthcare stocks have been hard hit by the broader market sell-offs over the past couple of months. But given the near-inelastic demand for healthcare solutions and the industry...
Brand evolution reflects breadth of clinical expertise and exclusive focus on providing the highest quality services across the women’s and children’s continuum of care Mednax, Inc. (NYSE: MD) today announced that its affiliated practices will adopt the Pediatr...
Leading industry conferences address the latest topics in neonatal management designed to improve outcomes for premature and critically ill newborns Mednax, Inc. (NYSE: MD) and its Pediatrix-affiliated practices, the nation’s leading providers of highly specialized he...
Mednax, Inc. (NYSE: MD) today announced that it will present on Monday, February 28, 2022 at 10:00 a.m. ET to investors attending J.P. Morgan’s 2022 Global High Yield and Leveraged Finance Conference in Miami. The presentation will be broadcast through live audio webcasts. ...
MEDNAX, Inc. (MD) Q4 2021 Earnings Conference Call February 17, 2022, 9:00 AM ET Company Participants Mark Ordan – Chief Executive Officer Marc Richards – Chief Financial Officer Jim Swift – Chief Development Officer Charles Lynch – Senior Vice President, Finance &...
Mednax, Inc. (NYSE: MD) today announced that it will present on Friday, February 18, 2022 at 8:40 a.m. ET to investors attending SVB Leerink’s 11 th Annual Global Healthcare Conference, taking place virtually. The presentation will be broadcast through live audio webcasts. ...
Mednax press release (NYSE:MD): Q4 Non-GAAP EPS of $0.52 beats by $0.09. Revenue of $499M (+19.7% Y/Y) beats by $16.5M. On a preliminary basis, Mednax anticipates that its 2022 Adjusted EBITDA, as defined above, will be at least $270 million. For further details see: Mednax Non-GAAP EPS...
Mednax (NYSE:MD) is scheduled to announce Q4 earnings results on Thursday, February 17th, before market open. The consensus EPS Estimate is $0.43 (+72.0% Y/Y) and the consensus Revenue Estimate is $482.5M (+15.7% Y/Y). Over the last 2 years, MD has beaten EPS estimates 63% of the time and has...
Carlyle Group (CG -0.6%) has named Linda Hefner Filler, a former Walgreen (NASDAQ:WBA) executive, and Mednax (NYSE:MD) CEO Mark Ordan to its board, effective April 1, 2022. Meanwhile, Janet Hill retired from the board after a decade of service. The two new addition and the retirement will inc...
Redeems 6.25% Senior Notes Due 2027 Mednax, Inc. (NYSE: MD) (“Mednax”) announced today that on February 11, 2022 it closed the previously announced issuance of $400.0 million aggregate principal amount of unsecured 5.375% Senior Notes due 2030 (the “ N...
News, Short Squeeze, Breakout and More Instantly...
Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, August 6, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2024. A detailed press release will be issued the morning of August 6, 2024 before the securities...
MONTREAL, July 09, 2024 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the start of a drilling campaign on the Patris gold property (the “ Property ”), currently 100% owned by Midland and located approximately 3...
MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the commencement of a major exploration program for nickel and copper in Nunavik, following up on exploration work carried out from 2020 to 2023 during which new N...